Get the latest tech news
Marketing Cancer Drugs To Physicians Increases Prescribing Without Improving Mortality
Abstract of a paper on National Bureau of Economic Research: Physicians commonly receive marketing-related transfers from drug firms. We examine the impact of these relationships on the prescribing of physician-administered cancer drugs in Medicare. We find that prescribing of the associated drug in...
Abstract of a paper on National Bureau of Economic Research: Physicians commonly receive marketing-related transfers from drug firms. A marketing payment also leads physicians to begin treating cancer patients with lower expected mortality. While payments result in greater expenditure on cancer drugs, there are no associated improvements in patient mortality.
Or read this on Slashdot
